Neonatal deletion of Yap in Scx-lineage cells disrupts collagen production in the tendon during postnatal development. by Heather L. Dingwall (14573796)

“…<b>E)</b> RT-qPCR shows decreased expression of Col1a2, Ki67, and Yap in and Yap-cKO tendon at P14 compared to controls. …”

Lesioning silent neurons reveals functional role. by Thomas S. Wierda (22404198)

“…<p><b>a</b> We lesioned neurons that were silent by forcing their firing rate to be zero at every timestep. …”

PPI network analysis. by Du Leng (20421711)

ELISA of the key proteins. by Du Leng (20421711)

“…KEGG pathway analysis showed a significant enrichment of DEPs in PI3K-Akt pathway and focal adhesion. …”

S1 Data - by George Mrema (19550255)

“…Additionally, despite the observed decline in point prevalence and new case detection rates, these changes were not statistically significant. …”

The mRNA (A) and protein (B) levels of <i>NlPHB2</i> in viruliferous and nonviruliferous <i>N. lugens</i> determined by RT-qPCR and Western blot assays at 6 dpvf. by Lianshun Zheng (22086585)

RV PV loop eccentricity during CPR. by Woo Jin Jung (3279570)

F05 demonstrates additive anti-tumor effects in combination with mAb therapy and reprograms M2 macrophages towards a phagocytotic phenotype. by Keifer G. Kurtz (21416918)

“…CD163 MFI is significantly decreased with F05 treatment (p = 0.0089, 55% decrease), but not 1H9 (p = 0.0828, 31% decrease) when compared to RITUX.…”

Volitional control frequency and intensity in VH (Kapsner-Smith et al., 2025) by Mara R. Kapsner-Smith (22139315)

“…<i>Journal of Speech, Language, and Hearing Research, </i><i>68</i>(10), 4736–4748. <a href="https://doi.org/10.1044/2025_JSLHR-25-00182" rel="noreferrer" target="_blank">https://doi.org/10.1044/2025_JSLHR-25-00182</a></p>…”

Histological appearance of NT2 CisR xenograft tumors without (A) and with (B) DNase treatment, and quantification of intratumoral microvascular density (C). by Mego Michal (22783828)

Expression of ‘muscle’ genes in the tendon during early postnatal development. by Heather L. Dingwall (14573796)

Percentages of pediatricians and obstetricians/gynecologists working long hours, based on the desired working environment. by Mai Nakagawa (20284927)

Genotypic distribution of rs12529 in the study subjects. by Md. Akeruzzaman Shaon (21511929)

The RehaGait® system. by Johanna Rydja (12300797)

“…</p><p>Trial registration</p><p>ClinicalTrials.gov <a href="https://clinicaltrials.gov/ct2/show/NCT04795089" target="_blank">NCT04795089</a></p></div>…”

Flow chart of included patients and dropouts. by Johanna Rydja (12300797)

“…</p><p>Trial registration</p><p>ClinicalTrials.gov <a href="https://clinicaltrials.gov/ct2/show/NCT04795089" target="_blank">NCT04795089</a></p></div>…”

Dataset of the analyzed data. by Johanna Rydja (12300797)

“…</p><p>Trial registration</p><p>ClinicalTrials.gov <a href="https://clinicaltrials.gov/ct2/show/NCT04795089" target="_blank">NCT04795089</a></p></div>…”

Root mean square fluctuations of the wild-type (green line) and mutant (H5Q) (purple line) proteins of AKR1C3 (complexed with the ligand NADPH). by Md. Akeruzzaman Shaon (21511929)

Dissolved vanadate concentration in culture and control experiments over time. by Bokyung Kim (622579)

<i>DQ6</i> protection as a function of iKIR score. by Laura Mora-Bitria (20477525)

The expression of PAX7 and MYOD1 correlate with differential expression of diverse chemokines in HuMuSC. by Katharine Striedinger (15503387)

“…<p><b>(a)</b> Quantification of protein expression for PAX7+ and MYOD1 positive HuMuSC at day 0, 3 and 6 in vitro, showing an inverse correlation as progressively PAX7 expression decreases and MYOD1 expression increases in HuMuSC as they activate <i>in vitro</i>. …”